Articles

  • 2 weeks ago | medcentral.com | Eric J. Topol |Ivan Oransky

    In this timely interview, Eric Topol, MD, discusses with Ivan Oransky, MD, key clinical takeaways from his new book, Super Agers: An Evidence-Based Approach to Longevity, published this month by Simon & Schuster. On the docket: what physicians can do now to help prevent the top three age-related diseases – cardiovascular disease, cancer, and neurodegenerative disease – in their patients, the overlooked role of the immune system, and why GLP-1s are outperforming all expectations.

  • 1 month ago | cambridge.org | Ivan Oransky |Adam Marcus

    Hostname: page-component-f554764f5-rvxtl Total loading time: 0 Render date: 2025-04-14T10:39:55.277Z Has data issue: false hasContentIssue false Published online by Cambridge University Press:  14 April 2025 Ivan Oransky [Opens in a new window]  and Show author details Keywords research misconductfraudinvestigationsuniversities Type Symposium Information Journal of Law, Medicine & Ethics , First View , pp.

  • 1 month ago | medcentral.com | Marc E. Agronin |Ivan Oransky |Charles Piller |Greg Sackuvich

    The oral NMDA receptor antagonist/sigma-1 receptor agonist AXS-05 significantly delayed and prevented Alzheimer’s disease agitation relapse compared with placebo, according to results of the ACCORD-2 trial presented at the 2025 American Academy of Neurology annual meeting held in San Diego this week. “These results support the use of AXS-05 as a safe and effective treatment for AD agitation,” said George Grossberg, MD, of Saint Louis University School of Medicine, St. Louis, MO.

  • Feb 20, 2025 | inquisitivemag.org | Ivan Oransky |Adam Marcus

    If you’re anything like us, when you take a pill, drive over a bridge, or make other important decisions, you want to know those choices are based on solid evidence.

  • Oct 1, 2024 | library.nd.edu | Ivan Oransky

    Scientific Integrity and Retractions: A Talk By Ivan OranskyOctober 1, 202412:30 pm – 1:30 pmDr. Oransky will explore the complexities of scientific retractions, misconduct, and the importance of transparency in research. Drawing on his experience as co-founder of Retraction Watch and his work in scientific journalism, Dr. Oransky will discuss the hidden factors affecting scientific integrity and how the research community can promote accountability.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →